HULIO
ADALIMUMAB
Public price
4,18 MAD
Active substance
ADALIMUMAB
Laboratory
SYNTHEMEDIC
What is this medicine?
HADLIMA (adalimumab-bwwd) is a biosimilar to HUMIRA (adalimumab) that acts as a tumor necrosis factor (TNF) blocker.
Verified summary
ADALIMUMAB, SOLUTION INJECTABLE, 40 MG / 0,8 ML, BOITE DE 2
Common uses
moderately to severely active rheumatoid arthritis,moderately to severely active polyarticular juvenile idiopathic arthritis,active psoriatic arthritis,active ankylosing spondylitis,moderately to severely active Crohn’s disease,moderately to severely active ulcerative colitis,moderate to severe chronic plaque psoriasis,moderate to severe hidradenitis suppurativa,non-infectious intermediate, posterior, and panuveitis
Class
tumor necrosis factor (TNF) blocker
Laboratory
SYNTHEMEDIC
Hospital price
3,90 MAD
Strength
40 MG / 0,8 ML
Form
SOLUTION INJECTABLE
Presentation
BOITE DE 2
Commercial status
Commercialisé AO
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-01: 4,18 MAD
Available presentations and strengths
Medicines with the same active substance
HUMIRA 40MG
40 MG · 1 BOITE 2 SERINGUE PREREMPLIE
0,00 MAD
HUMIRA 40MG
40 MG · 1 BOITE 2 STYLO PRE-REMPLI
0,00 MAD
HUMIRA
20 MG / 0,2 ML · BOITE DE 2
3,26 MAD
DALMAB
40 MG · BOITE DE 2 SERINGUES PREREMPLIES AVEC 2 TAMPONS D’ALCOOL
4,17 MAD
DALMAB
40 MG · BOITE DE 2 STYLOS PREREMPLIS AVEC 2 TAMPONS D’ALCOOL
4,17 MAD
YUFLYMA
40 MG / 0,4 ML · BOITE DE 2 STYLOS PRÉ-REMPLIS AVEC CHACUN 1 TAMPON D'ALCOOL
4,17 MAD
DALMAB
80 MG · BOITE DE 1 SERINGUE PREREMPLI AVEC 1 TAMPONS D’ALCOOL
4,41 MAD
HYRIMOZ
40 MG / 0,8 ML · BOITE DE 2 STYLOS PREREMPLIS
4,52 MAD
AMGEVITA
40 MG · BOITE DE 2
4,82 MAD
AMGEVITA
40 MG · BOITE DE 2
4,82 MAD
HUMIRA
40 MG / 0,4 ML · BOITE DE 2
5,84 MAD
HUMIRA
40 MG / 0.4 ML · BOITE DE 1
5,84 MAD